Highest-materiality recent filing
Marcum resigned as auditor on June 26, 2025; CBIZ CPAs engaged for year ended Dec 31, 2024.
Cell Source completes $4.76M offering of 8% convertible notes with warrants
Completed private offering of $4,760,170 aggregate principal of 8% convertible notes.
Two directors resign from Cell Source board, no disagreements cited
Ben Friedman resigned as director on July 18, 2022.
Director Itamar Shimrat resigns from board, remains CEO
On May 6, 2022, Itamar Shimrat resigned as director of Cell Source, Inc.
Cell Source issues $2.5M convertible note to new board member George Verstraete at 10% interest
Appointed George Verstraete to the board; he agreed to loan $2.5M via a convertible promissory note.
On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).
On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).
On May 6, 2022 Itamar Shimrat resigned his position as a director of Cell Source, Inc.
On March 10, 2022, the Board of Directors of the Company appointed George Verstraete as a member of the Board.
Max materiality 0.70 · Median 0.50 · Most common event debt